Eu­ro­pean AI start­up rais­es $24M for pro­tein de­sign soft­ware ser­vice

A Eu­ro­pean start­up is bet­ting that drug com­pa­nies big and small will look to out­source ar­ti­fi­cial in­tel­li­gence ex­per­tise that can help de­sign new pro­tein-based med­i­cines.

Cra­dle said Mon­day that it raised $24 mil­lion in Se­ries A fund­ing to re­fine its gen­er­a­tive AI soft­ware for con­coct­ing new pro­teins or im­prov­ing ex­ist­ing ones. And rather than build­ing an in­ter­nal pipeline of drug pro­grams, Cra­dle is square­ly a soft­ware-as-a-ser­vice com­pa­ny, CEO and co-founder Stef van Grieken told End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER